Q&A Insights
Explore more insights from key opinion leaders in exclusive Q&As and written articles:
Dermatology Times is recapping our exclusive expert interviews from the month of August.
Whitney Hovenic, MD's new SPOOGE sunscreen hopes to engage Gen Z in sun protection, merging skincare with fun and effective sun care strategies.
Explore more insights from key opinion leaders in exclusive Q&As and written articles:
Dendy Engelman, MD, FACMS, FAAD, explores the latest advancements in laser and energy-based dermatological treatments, including skin resurfacing and body contouring.
Discover Anthony Rossi, MD, FAAD, FACMS's innovative skin care line targeting inflammatory aging with clinical science, clean formulations, and effective anti-aging solutions.
James Song, MD, FAAD, reveals insights on abrocitinib's safety in atopic dermatitis, highlighting lower conjunctivitis rates compared to dupilumab at DERM 2025.
Case reports showed encouraging outcomes in eczema, but the company is pursuing deeper validation.
Nektar Therapeutics explores rezpegaldesleukin's potential as a groundbreaking treatment for alopecia areata, aiming for FDA approval and improved patient outcomes.
Steven Daveluy, MD, highlighted lack of awareness and early misdiagnosis as major barriers to effective HS care.
Andrade's inspiring journey highlights the challenges of HS and the transformative impact of clinical trials.
Strong mentorship provides resilience for young clinicians navigating evolving challenges in practice.
Discover how biologic coordinators streamline dermatologic care through detailed protocols, clinical documentation, and patient advocacy to improve access to life-changing biologic therapies.
Virginia Sybert, MD, emphasized the importance of using genetic testing judiciously in dermatologic care.
Shanna Miranti, MPAS, PA-C, discusses the impact of sleep loss in pediatric atopic dermatitis and the potential of emerging therapies in young patients, such as ruxolitinib cream, to improve outcomes.
Tina Bhutani, MD, MAS, discusses innovative pediatric atopic dermatitis treatments, including ruxolitinib cream, emphasizing collaborative decision-making for effective management.
Walter Liszewski, MD, discusses the personalized and evolving treatment landscape for moderate to severe AD, emphasizing a tailored approach using new biologics and non-steroidal topicals to meet individual patient needs and expectations.
At DERM 2025, David Cotter, MD, PhD, shared how GEP testing revolutionizes skin cancer management and enhances patient care at the forefront of dermatology innovation.
World Skin Health Day unites global dermatology leaders to enhance skin health awareness, access, and equity in underserved communities worldwide.
A recent HS Summit hosted by UCB brought together clinicians and patient advocates to strengthen research and awareness efforts.
In celebration of World Skin Health Day, Jasmin Jamora, MD, and her team at PDS enhance skin health access in remote areas through outreach clinics and education.
Vinna Crisostomo, MD, leads vital skin health initiatives in Palawan, addressing access and education challenges for underserved communities on World Skin Health Day.
Don’t miss a moment of Dermatology Times by signing up for our
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.